Cantor Fitzgerald began coverage on shares of Bicycle Therapeutics (NASDAQ:BCYC) in a research note released on Monday morning, Benzinga reports....
Therapeutics
Bicycle Therapeutics Limited (NASDAQ:BCYC) was the target of a significant growth in short interest in September. As of September 15th,...
Shares of Bicycle Therapeutics Limited (NASDAQ:BCYC) have earned a consensus rating of “Buy” from the eight research firms that are...
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics...